ICCM

IceCure Medical Ltd

Healthcare · $2M market cap

Verdict

We can't put a fair value on ICCM right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-45.1% a year✗
Sales growth20.7% a year✓
Free cash flow growth—?
Return on invested capital-53.3%✗

Follow ICCM

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Nov 2, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Questions about ICCM

Are insiders buying ICCM?

Since Nov 2, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar).

How can I check ICCM's value myself?

Use the free Sticker Price calculator, already filled with ICCM's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →

Similar stocks · Medical - Devices

About IceCure Medical Ltd

Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Nov 3, 2026. How the Payback Price works